Palmitoyl tripeptide-1 is a cosmeceutical peptide.

Besifovir maleate (formerly known as ANA-380 maleate; LB-80380 maleate; PMCDG dipivoxil maleate; Korea Trade name: Besivo) is a reverse transcriptase inhibitor that has been approved in Korea to treat hepatitis B virus (HBV) infection. It is a novel and potent acyclic nucleotide phosphonate with a similar chemical structure to adefovir and tenofovir. Besifovir is a […]

Ret-IN-1, a Selpercatinib analog, is a novel, potent, orally bioavailable and selective a RET kinase inhibitor with anticancer activity. It was mistakenly listed as LOXO-292 (ARRY-192 or Selpercatinib). It is an investigational drug in clinical development for the treatment of patients with cancers that harbor abnormalities in the rearranged during transfection (RET) kinase. Selpercatinib (LOXO-292; […]

Trastuzumab (trade name Herceptin; Anti-Human HER2, Humanized Antibody) is a humanized monoclonal antibody used to treat invasive breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just […]

Adalimumab (trade name Humira; also known as Anti-Human TNF-alpha, Human Antibody) is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α). Adalimumab is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who […]

Bevacizumab (trade name Avastin; Anti-Human VEGF, Humanized Antibody) is a humanized monoclonal antibody which binds specifically to all VEGF-A isoforms with high affinity. It is a medication used to treat a number of types of cancers and a specific eye disease. For cancer it is given by slow injection into a vein and used for […]

Tripeptide-10 Citrulline is a novel cosmeceutical peptide which specifically targets collagen fibre organization to regulate collagen fibrillogenesis.

Ustekinumab (brand name Stelara; Anti-Human IL-12/IL-23, Human Antibody) is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody used to treat psoriasis. It is also approved to treat Crohn’s disease in the United States among people who have not responded to more traditional treatments. It was found not effective for multiple sclerosis

Vaniprevir (formerly known as MK-7009) is a non-covalent competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease. It is is a macrocyclic that is being developed by Merck & Co., and is currently in clinical testing. In Japan, it was approved in Japan for treating hepatitis C in 2014 under the brand name Vanihep. […]

AP3 Impurity 1 is a bioactive molecules.